New patent for Blueprint Medicines drug GAVRETOBy DrugPatentWatch – Make Better Decisions / May 15, 2024 Annual Drug Patent Expirations for GAVRETO Gavreto is a drug marketed by Blueprint Medicines and is included in one NDA. It is available from one supplier. There are three patents…Source